Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: rocuronium

August 18, 2025 CD as API / CD derivatives / Pharma applications

Results of Phase III clinical trial on efficacy and safety of Adamgammadex

This multicentre, randomised, double-blind, positive-controlled, noninferiority phase III clinical trial aimed to investigate the efficacy and safety of adamagammadex compared

Continue reading

July 26, 2022 CD as API / Pharma applications

Novel Case Study with Sugammadex in Pregnant Women

The use of sugammadex (SGM) after caesarean section is nowadays common practice, but there haven’t been reported any case studies

Continue reading

September 28, 2021 CD as API / Pharma applications

Comparison of Selective Relaxant Binding Agent Adamgammadex Sodium with Sugammadex for Reversing Rocuronium-Induced Deep Neuromuscular Block

Zhao et al. reported on a phase IIa, single-center, randomized, open-label, and dose-finding study that enrolled 35 patients under general

Continue reading

August 24, 2021 CD as API / Pharma applications

Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: an ex vivo laboratory study

Residual neuromuscular block at the end of surgery may compromise the patient’s safety. The risk of airway complications can be

Continue reading

Recent Posts

  • In Vitro and Ex Vivo Studies on the Absorption and Distribution of β-Cyclodextrin Polymer
  • Positively Charged Fluorine-Free Cyclodextrin Nanosponges for PFAS Removal
  • Impact of Cholesterol Depletion by methyl BCD on Dopamine Transmission Dynamics in Brain
  • Special Issue “Cyclodextrin-Functionalized Materials for Drug Delivery, Pharmaceutical and Medical Applications”
  • Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (72)
  • CD as API (351)
  • CD derivatives (424)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (804)
  • E-ducation (63)
  • Environmental (141)
  • Events (236)
  • Food (229)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (409)
  • Other industrial use (110)
  • Pharma applications (1,202)
  • Supramolecular systems (44)
  • Uncategorized (161)

Top Posts

  • Positively Charged Fluorine-Free Cyclodextrin Nanosponges for PFAS Removal
  • In Vitro and Ex Vivo Studies on the Absorption and Distribution of β-Cyclodextrin Polymer
  • CDs for the removal of PFAS; A review
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • Cyclodextrin polymers containing ionizable and ionic groups: A comprehensive review from classifications and synthesis methods to applications.
  • How air fresheners work?
  • Use of odor-absorbing component, Hydroxypropyl-β-cyclodextrin in a new Japanese personal care product
  • Impact of Cholesterol Depletion by methyl BCD on Dopamine Transmission Dynamics in Brain
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • The Impact and Prospects of Green Chemistry for Textile Technology

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...